1st/2nd Line Treatment Flashcards
(82 cards)
TTP
1st: Plasma Exchange
2nd: Steroids, rituximab
3nd: Splenectomy
Type 2 Diabetes Mellitus
1st: Metformin (Biguanide)
2nd: Add one:
- Want to lose weight / Heart disease: Dapagliflozin (SGL2-I)
- Can gain weight: Gliclazide (Sulfanylurea)
- Weight-Neutral: Sitagliptin (DPP4)
3rd line: Add another of the above
4th line: Swap one of the above for another.
5th line: Insulin
Hyperthyroidism
1st line: Multiple, depends on the patient.
- Radioactive Iodine: Don’t use in pregnancy
- Thyroidectomy + Levothyroxine
- Carbimazole +- Levothyroxine.
Hypothyroidism
1st line: Titrate levothyroxine.
Prolactinoma
1st line: Cabergoline (Dopamine agonist).
Gold standard: Transsphenoidal surgery.
Acromegaly
Gold standard and 1st line:
Transsphenoidal surgery
2nd line(surgery refused):
SST analogue (Octreotide)
3rd line: Cabergoline/Bromocriptine (Dopamine agonist).
Neurogenic Diabetes Insipidus
1st line: Desmopressin + Thiazide.
Renal Colic
1st line:
IM Diclofenac
Expectant +-tamsulosin (∂-blocker) considered for stones <5mm
2nd line (Post NC-CTKUB):
-Lithotripsy if the stone is 5-20mm
-Uteroscopy if stones 10-20mm (overlap)
-Percutaneous Lithotomy if stones >20mm.
Pyelonephritis / Hydronephrosis:
-Emergency decompression
Gout
Acute 1st line: Colchicine (Anti-inflammatory)
Long-term 1st line: Allopurinol
Rheumatoid arthritis
1st: DMARD:
Methotrexate / Leflunomide / Sulfasalazine (pregnant)
(NSAIDs and steroids while initiating MTX “Bridging”).
2nd: TNF-Blockers e.g., Infliximab
Glucocorticoids for flare-ups
ITP
No treatment required for children.
1st: glucocorticoids - prednisolone, IV IgG
2nd: Rituximab / High dose dexamethasone
Final resort: Splenectomy
Asthma
1st: SABA e.g. Salbutamol
2nd: Weak ICS e.g. Beclamethosone
3rd: LTRA e.g. Montelukast
4th: Stop LTRA and go for LABA e.g. Salmeterol
5th: Strong ICS e.g Beclamethosone
Migraine
-Mild-Moderate: Paracetamol and NSAIDs
-With Aura: Sumatriptan (Serotonin Agonist)
-Vomiting: Metoclopramide (Anti-Emetic)
-Prophylaxis:
1st line: Propanolol
(Avoid asthma)
2nd line: Topirimate
(Avoid Preg)
3rd line: Amitryptaline
Failure: 10 sessions of acupuncture.
Menstrual Migraines: Triptan mini-prophylaxis
Other: Riboflavin (vB2) OD
Polycythaemia
1st line:
-Aspirin OD
-Regular venesection
Other:
-Allopurinol (Gout prophylaxis)
-Hydroxycarbamide
Hypocalcaemia
1st: IV Calcium gluconate 10mL 10% over 10 mins if severe.
2nd: AdCal + Treat underlying.
Addison’s disease
1st line: oral glucocorticoids
Adrenal crisis - IV saline and hydrocortisone
Hypoglycaemia
1st:
Glucogel 10-20g PO if they have a safe-swallow.
2nd:
-IV Glucose 20% (If you have access)
3rd:
IM Glucagon if no IV access (LESS EFFECTIVE IF ON SULFANYLUREA)
Heart Failure (Reduced EF)
1st: ACE-I and Beta-Blocker (No mortality benefit in PRESERVED-EF)
2nd/Preserved EF: Spironolactone +-SGLT2-Inhibitors
3rd: Possibly Ivabradine (If HR >75 and LVEF < 35%) / Digoxin
Always add some furosemide if symptoms; no good for mortality.
Heart Failure (Preserved EF)
1st: SGLT-Inhibitor; Dapagliflozin
(ACE-Is and Beta-Blockers have no mortality benefit)
Always add furosemide for symptoms; no mortality benefit.
May deteriorate to reduced EF; Go to that treatment then.
Paget’s disease
1st: Analgesia & bisphosphonates
2nd: Surgery to correct bone deformities
Osteoporosis
1st line: AdCal-D3 & bisphosphonates
2nd line: Denosumab – monoclonal antibody to RANK ligand
Supraventricular tachycardia
Acute:
- Valsalval maneuver
- Adenosine (or Verapamil in asthmatic pt)
Long term: ß-blockers, Ca-blockers, Amiodarone (K+ blocker)
Tension pneumothorax
1st: Needle decompression - 2nd intercostal space, midclavicular
2nd: Chest drain
Simple Pneumothorax
1st:
-No Symptoms: even if large: Observe +-O2 over 4-6 hours and discharge.
-Symptoms AND >2cm (or safe to intervene):
Assess high-risk characteristics:
Smoke and >50, Hypoxia / Haemodynamic Instab, Bilateral, or SECONDARY, or FAILED NEEDLE.
Present = CHEST DRAIN
Not Present = NEEDLE
-Success when <2cm afterwards.
-EVERY secondary patient will get admitted for monitoring.
-All patients followed-up in 2-4 weeks.